REQUEST A DEMO
Total
USD $0.00
Search more companies

Novartis Ecuador S.A. (Ecuador)

Main Activities: Medicinal and Botanical Manufacturing | Pharmaceutical Preparation Manufacturing | Biological Product (except Diagnostic) Manufacturing
Secondary Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Novartis Ecuador S.A. Profile Updated: June 16, 2022
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English & Spanish Download a sample report

Novartis Ecuador was incorporated in 1975 under the legal denomination Ciba Geigy Ecuatoriana S.A. In 1997 the company changed its name to Novartis Ecuador S.A. It is a subsidiary of Novartis Pharma AG, economic entity located in Switzerland, which operates the Novartis group, a multinational pharmaceutical corporation. The main activity of the company is the import, production and sale of chemical products, pharmaceuticals, cosmetics and all type of products related to the chemical industry. Novartis´ business is divided into three divisions: pharmaceuticals, eye-care products and generics. It has also established a research organisation, Institutes of Investigation Biomedica de Novartis that facilitate the cooperation between the different business lines.

Headquarters
Av. Amazonas N37-29, Eurocenter Bldg. , Floor 2
Quito; Pichincha;

Contact Details: Purchase the Novartis Ecuador S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Novartis Ecuador S.A. report to view the information.
Outstanding Shares:
Purchase the Novartis Ecuador S.A. report to view the information.
Registered Capital:
Purchase the Novartis Ecuador S.A. report to view the information.
Financial Auditors:
Purchase the Novartis Ecuador S.A. report to view the information.
Ratings:
Purchase the Novartis Ecuador S.A. report to view the information.
Incorporation Date:
October 01, 1975
Key Executives
Purchase this report to view the information.
Executive President
Purchase this report to view the information.
Chairman
Ownership Details
Purchase this report to view the information.
99.72%
Purchase this report to view the information.
0.28%
Subsidiaries
Company Performance
Financial values in the chart are available after Novartis Ecuador S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-4.89%
Total operating revenue
-4.17%
Operating profit (EBIT)
-16.6%
EBITDA
1.57%
Net Profit (Loss) for the Period
N/A
Total assets
-19.47%
Total equity
0.33%
Operating Profit Margin (ROS)
-0.37%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
44.52%
Quick Ratio
-0.05%
Cash Ratio
-0.08%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?